Critical illness polyneuropathy and myopathy (CIPNM): Evidence for local immune activation by cytokine-expression in the muscle tissue

Journal of Neuroimmunology

Volumn 106, Issue 1-2, 2000, Pages 206-213

  De Letter, M A C J ^a,b   Van Doorn, P A ^b   Savelkoul, H F J ^b   Laman, J D ^b   Schmitz, P I M ^b   Op De Coul, A A W ^a   Visser, L H ^a   Kros, J M ^b   Teepen, J L J M ^a   Van Der Meche F G A ^b  

^a CPRLab   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Critical illness polyneuropathy and myopathy; Cytokines; Immune activation; Immunohistochemistry; Muscle biopsy; Sepsis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; CYTOKINE RELEASE; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSTIMULATION; LEUKOCYTE ACTIVATION; MACROPHAGE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANTIGENS, CD; CRITICAL ILLNESS; CYTOKINES; HLA-DR ANTIGENS; HUMANS; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; INCIDENCE; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; LONGITUDINAL STUDIES; MUSCLES; MUSCULAR DISEASES; NETHERLANDS; POLYNEUROPATHIES; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 0034237434     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00252-0     Document Type: Article

References (23)

1. Al-Lozi M.T., Pestronk A., Yee W.C., Flaris N., Cooper J. Rapidly evolving myopathy with myosin-deficient muscle fibers. Ann. Neurol. 35:1994;273-279.
2. Bazzi, P., Moggio, M., Prelle, A., Battistel, A., Sciacco, M., Adobbati, L., Checcarelli, N., Peelegrini, G., Scarlato, G. 1996. Inflammatory myopathy in intensive care patients. J. Neurol. 243 (Suppl 2), S111, Abstract.
3. Bolton C.F. Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations. Crit. Care Med. 8:1996;1408-1416.
4. Bolton C.F., Gilbert J.J., Hahn A.F., Sibbald W.J. Polyneuropathy in critically ill patients. J. Neurol. Neurosurg. 47:1984;1223-1231.
5. Bolton C.F., Young G.B., Zochodne D.W. The neurological complications of sepsis. Ann. Neurol. 33:1993;94-100.
6. Coakley J.H., Nagendran K., Honavar M., Hinds C.J. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med. 19:1993;323-328.
7. Danon M.J., Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve. 14:1991;1131-1139.
8. Debets R., Savelkoul H.F.J. Cytokines as cellular communicators. Mediators Inflammation. 5:1996;417-423.
9. Dubowitz, V. 1985. Definition of pathological changes seen in muscle biopsies. In: Dubowitz V. (Ed.) Muscle Biopsy a Practical Approach, Ballière Tindall, East Sussex, pp. 82-129.
10. Gutmann L., Blumenthal D., Gutmann L., Schochet S.S. Acute type-II myofiber atrophy in critical illness. Neurology. 46:1996;819-821.
11. Hoefakker S., Boersma W.J.A., Claassen E. Detection of human cytokines in situ using antibody and probe based methods. J. Immunol. Meth. 185:1995;149-175.
12. Hohlfeld R., Engel A.G. The immunobiology of muscle. Immunol. Today. 15:1994;269-274.
13. Hund E., Genzwürker H., Böhrer H., Jakob H., Thiele R., Hacke W. Predominant involvement of motor fibers in patients with critical illness polyneuropathy. Br. J. Anaesth. 78:1997;274-278.
14. Latronico N., Fenzi F., Recupero D., Guarneri B., Tomelleri G., Tonin P., De Maria G., Antonini L., Rizzuto N., Candiani A. Critical illness myopathy and neuropathy. Lancet. 347:1996;1579-1582.
15. Lundberg I., Ulfgren A., Nyberg P., Andersson U., Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 40:1997;865-874.
16. Op de Coul A.A.W., Lambregts P.C.L.A., Koeman J., van Puyenbroek M.J.E., Ter Laak H.J., Gabreëls-Festen A.A.W.M. Neuromuscular complications in patients given Pavulon (pancuroniumbromide) during artificial respiration. Clin. Neurol. Neurosurg. 87:1985;17-22.
17. Op de Coul A.A.W., Verheul A.A.W., Leyten A.C.M., Schellens R.L.L.A., Teepen J.L.J.M. Critical illness polyneuromyopathy after artificial respiration. Clin. Neurol. Neurosurg. 93:1991;27-33.
18. Stevens L.E. Gauging the severity of surgical sepsis. Arch. Surg. 118:1983;1190-1192.
19. Subramony S.H., Carpenter D.E., Seshadri R., Pride M., Evans O.B. Myopathy and prolonged neuromuscular blockade after lung-transplant. Crit. Care Med. 19:1991;1580-1582.
20. Tews D.S., Goebel H.H. Cytokine expression profile in idiopathic inflammatory myopathies. J. Neuropathol. Exp. Neurol. 55:1996;342-347.
21. Verheul G.A.M., de Jongh-Leuvenink J., Op de Coul A.A.W., van Landeghem A.A.J., van Puyenbroek M.J.E. Tumor necrosis factor and interleukin-6 in critical illness polyneuro(myo)pathy. Clin. Neurol. Neurosurg. 96:1994;300-304.
22. Wokke J.H.J., Jennekens F.G.I., van den Oord C.J.M., Veldman H., van Gijn J. Histological investigations of muscle atrophy and end plates in two critically ill patients with generalized weakness. J. Neurol. Sci. 88:1988;95-106.
23. Zochodne D.W., Bolton C.F., Wells G.A., Gilbert J.J., Hahn A.F., Brown J.D., Sibbald W.A. Critical illness polyneuropathy. A complication of sepsis and multi organ failure. Brain. 35:1987;575-584.